An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice
Sima Qutaina, Haitian ZHAO, Zhiming Wang, Caterina Ivaldo, Santiago Ruiz, Andy Sullivan, Erin Murphy, Philippe Marambaud
A peptide vaccine targeting ANG2 reduces AVM number and size and normalizes vascular diameters in HHT mice without causing organ dysfunction.
Blood Vessels Thrombosis & Hemostasis · Mar 10, 2026Peer-reviewedCell Biology